Morten Maltesen

Morten Maltesen currently serves as VP of Pharmaceutical Development at Ascendis Pharma since March 2024. Prior to this role, Morten was Director for Business Integration in Emerging Technologies Portfolio Management at Novo Nordisk from November 2022 to February 2024, and Head of OPF Project Office at Nanovi A/S from January to November 2022. Morten has extensive experience in regulatory affairs, project management, and R&D within the pharmaceutical and biotechnology sectors, having held various leadership positions at Novo Nordisk and Novozymes. Educational qualifications include a PhD in Pharmaceutical Sciences from the University of Copenhagen, a Diploma in Engineering Business Administration from DTU, and a Master of Science in Engineering, Biotechnology from DTU, along with experience as a visiting researcher at The University of Kansas.